Cryopreservation involves the use of very
low temperatures for the preservation of cells and tissues. Biomedical
warming and thawing devices aid in the warming and thawing of
cryopreserved products. Cyropreservative chemicals can damage living
cells preserved for a longer duration. Therefore, warming them from the
frozen state should take place at a rapid pace till complete thawing is
achieved. The frozen cells are rapidly thawed in a water bath at 37°C
and then the cells are transferred to pre-warmed growth medium. After
thawing, transferring the content of the vials in the medium is
important in order to minimize the exposure of cells to cyropreservative
agents. Hence, warming and thawing devices are important to reduce the
effect of cyropreservatives on the cells, ensuring their viability for
use in various purposes in health care and research.
A rise in the number of accident and trauma cases, increase in demand for blood transfusion, and rise in demand for point-of-care thawing device technology are anticipated to drive the global biomedical warming and thawing devices market. Additionally, strategic approaches by market players such as product launches, collaborations, and partnerships are further likely to fuel the growth of the global biomedical warming and thawing devices market during the forecast period. For instance, in December 2018, Pluristem Therapeutics Inc., a regenerative medicine company manufacturing placenta-based cell therapy products, entered into a license agreement with a subsidiary of Chart Industries, Inc. in regards to the company`s thawing device for cell-based therapies. As per the agreement, Chart obtained exclusive rights to develop and market the thawing device worldwide, except in China. In November 2016, Cook and Asymptote, a U.K.-based company, launched water-free automated cell thawing technology. In November 2014, BioCision, a U.S.-based life science research and development company, launched an automated sample thawing system named ThawSTAR to address the need of thawing cells during cryopreservation.
Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59046
The global biomedical warming and thawing devices market can be segmented based on product, sample, end-user, and region. In terms of product, the global biomedical warming and thawing devices market can be divided into manual and automated devices. The automated devices segment is projected to account for a prominent market share during the forecast period, due to an increase in the demand for automation in life sciences facilities and rise in the number of prominent players offering these devices in the market. Based on sample, the global biomedical warming and thawing devices market can be classified into blood products, ovum/embryo, and semen. In terms of end-user, the global biomedical warming and thawing devices market can be categorized into blood banks & transfusion centers, hospitals, research laboratories, pharmaceutical companies. The blood banks and transfusion centers segment is anticipated to expand at a rapid CAGR during the forecast period, due to an increase in the use of biomedical devices for processing blood and other samples required during transfusion.
Based on region, the global biomedical
warming and thawing devices market can be segmented into North America,
Europe, Asia Pacific, Latin America, and Middle East & Africa. North
America is projected to account for a prominent market share during the
forecast period, due to an increase in the importance of
cryopreservation of cells and blood products and the presence of key
players manufacturing these devices in the U.S.. The market in Europe is
anticipated to expand at a rapid pace during the forecast period, due
to a rise in demand for technologically advanced biomedical warming and
thawing devices and extensive research activities on blood products in
countries such as the U.K., Germany, and France. The biomedical warming
and thawing devices market in Asia Pacific is expected to expand at a
rapid CAGR during the forecast period, driven by a rise in awareness
about cell viability and quality based products for research, increase
in the use of biomedical devices, and strengthening of health care
infrastructure in emerging markets in Asia Pacific. The biomedical
warming and thawing devices market in Middle East & Africa is driven
by significant demand for quality care devices and rapid expansion of
medical technologies and increase in the use of automated medical
systems.
Key players operating in the global biomedical warming and thawing devices market are Helmer Scientific, BioCision, General Electric Company, Sartorius AG, Sarstedt AG & Co. KG, Boekel Scientific, CytoTherm, Cardinal Health, Barkey, and Thermo Fisher Scientific.
No comments:
Post a Comment